1. Home
  2. HTCR vs QNRX Comparison

HTCR vs QNRX Comparison

Compare HTCR & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

HOLD

Current Price

$0.43

Market Cap

11.7M

Sector

Technology

ML Signal

HOLD

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$12.32

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTCR
QNRX
Founded
2009
2018
Country
Japan
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
10.1M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
HTCR
QNRX
Price
$0.43
$12.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
193.6K
1.1M
Earning Date
11-18-2025
11-06-2025
Dividend Yield
29.89%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,189,136.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$5.01
52 Week High
$3.38
$41.80

Technical Indicators

Market Signals
Indicator
HTCR
QNRX
Relative Strength Index (RSI) 32.82 43.58
Support Level $0.42 $10.50
Resistance Level $0.48 $15.45
Average True Range (ATR) 0.04 2.79
MACD 0.00 -0.90
Stochastic Oscillator 13.40 17.04

Price Performance

Historical Comparison
HTCR
QNRX

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: